Monitor recorder optimized for electrocardiographic potential processing

ABSTRACT

Physiological monitoring can be provided through a lightweight wearable monitor that includes two components, a flexible extended wear electrode patch and a reusable monitor recorder that removably snaps into a receptacle on the electrode patch. The wearable monitor sits centrally (in the midline) on the patient&#39;s chest along the sternum oriented top-to-bottom. The placement of the wearable monitor in a location at the sternal midline, with its unique narrow “hourglass”-like shape, significantly improves the ability of the wearable monitor to cutaneously sense cardiac electrical potential signals, particularly the P-wave and, to a lesser extent, the QRS interval signals indicating ventricular activity in the ECG waveforms. Additionally, the monitor recorder includes an ECG sensing circuit that measures raw cutaneous electrical signals and performs signal processing prior to outputting the processed signals for sampling and storage.

CROSS-REFERENCE TO RELATED APPLICATION

This non-provisional patent application is a continuation of U.S. patentapplication Ser. No. 15/966,910, filed Apr. 30, 2018, pending, which isa continuation of U.S. Pat. No. 9,955,888, issued May 1, 2018, which isa continuation of U.S. Pat. No. 9,615,763, issued Apr. 11, 2017, whichis a continuation-in-part of U.S. Pat. No. 9,730,593, issued Aug. 15,2017, and further claims priority under 35 U.S.C. § 119(e) to U.S.Provisional patent application, Ser. No. 61/882,403, filed Sep. 25,2013, the disclosures of which are incorporated by reference.

FIELD

This application relates in general to electrocardiographic monitoringand, in particular, to a monitor recorder optimized forelectrocardiographic potential processing.

BACKGROUND

The first electrocardiogram (ECG) was invented by a Dutch physiologist,Willem Einthoven, in 1903, who used a string galvanometer to measure theelectrical activity of the heart. Generations of physicians around theworld have since used ECGs, in various forms, to diagnose heart problemsand other potential medical concerns. Although the basic principlesunderlying Dr. Einthoven's original work, including his naming ofvarious waveform deflections (Einthoven's triangle), are stillapplicable today, ECG machines have evolved from his original three-leadECG, to ECGs with unipolar leads connected to a central referenceterminal starting in 1934, to augmented unipolar leads beginning in1942, and finally to the 12-lead ECG standardized by the American HeartAssociation in 1954 and still in use today. Further advances inportability and computerized interpretation have been made, yet theelectronic design of the ECG recording apparatuses has remainedfundamentally the same for much of the past 40 years.

Essentially, an ECG measures the electrical signals emitted by the heartas generated by the propagation of the action potentials that triggerdepolarization of heart fibers. Physiologically, transmembrane ioniccurrents are generated within the heart during cardiac activation andrecovery sequences. Cardiac depolarization originates high in the rightatrium in the sinoatrial (SA) node before spreading leftward towards theleft atrium and inferiorly towards the atrioventricular (AV) node. Aftera delay occasioned by the AV node, the depolarization impulse transitsthe Bundle of His and moves into the right and left bundle branches andPurkinje fibers to activate the right and left ventricles.

During each cardiac cycle, the ionic currents create an electrical fieldin and around the heart that can be detected by ECG electrodes placed onthe skin. Cardiac electrical activity is then visually represented in anECG trace by PQRSTU-waveforms. The P-wave represents atrial electricalactivity, and the QRSTU components represent ventricular electricalactivity. Specifically, a P-wave represents atrial depolarization, whichcauses atrial contraction.

P-wave analysis based on ECG monitoring is critical to accurate cardiacrhythm diagnosis and focuses on localizing the sites of origin andpathways of arrhythmic conditions. P-wave analysis is also used in thediagnosis of other medical disorders, including imbalance of bloodchemistry. Cardiac arrhythmias are defined by the morphology of P-wavesand their relationship to QRS intervals. For instance, atrialfibrillation (AF), an abnormally rapid heart rhythm, can be confirmed byan absence of P-waves and an irregular ventricular rate. Similarly,sinoatrial block is characterized by a delay in the onset of P-waves,while junctional rhythm, an abnormal heart rhythm resulting fromimpulses coming from a locus of tissue in the area of the AV node,usually presents without P-waves or with inverted P-waves. Also, theamplitudes of P-waves are valuable for diagnosis. The presence of broad,notched P-waves can indicate left atrial enlargement. Conversely, thepresence of tall, peaked P-waves can indicate right atrial enlargement.Finally, P-waves with increased amplitude can indicate hypokalemia,caused by low blood potassium, whereas P-waves with decreased amplitudecan indicate hyperkalemia, caused by elevated blood potassium.

Cardiac rhythm disorders may present with lightheadedness, fainting,chest pain, hypoxia, syncope, palpitations, and congestive heart failure(CHF), yet rhythm disorders are often sporadic in occurrence and may notshow up in-clinic during a conventional 12-second ECG. Continuous ECGmonitoring with P-wave-centric action potential acquisition over anextended period is more apt to capture sporadic cardiac events. However,recording sufficient ECG and related physiological data over an extendedperiod remains a significant challenge, despite an over 40-year historyof ambulatory ECG monitoring efforts combined with no appreciableimprovement in P-wave acquisition techniques since Dr. Einthoven'soriginal pioneering work over a 110 years ago.

Electrocardiographic monitoring over an extended period provides aphysician with the kinds of data essential to identifying the underlyingcause of sporadic cardiac conditions, especially rhythm disorders, andother physiological events of potential concern. A 30-day observationperiod is considered the “gold standard” of monitoring, yet a 14-dayobservation period is currently pitched as being achievable byconventional ECG monitoring approaches. Realizing a 30-day observationperiod has proven unworkable with existing ECG monitoring systems, whichare arduous to employ; cumbersome, uncomfortable and not user-friendlyto the patient; and costly to manufacture and deploy. Still, if apatient's ECG could be recorded in an ambulatory setting over aprolonged time periods, particularly for more than 14 days, therebyallowing the patient to engage in activities of daily living, thechances of acquiring meaningful medical information and capturing anabnormal event while the patient is engaged in normal activities aregreatly improved.

The location of the atria and their low amplitude, low frequency contentelectrical signals make P-waves difficult to sense, particularly throughambulatory ECG monitoring. The atria are located posteriorly within thechest, and their physical distance from the skin surface adverselyaffects current strength and signal fidelity. Cardiac electricalpotentials measured dermally have an amplitude of only one-percent ofthe amplitude of transmembrane electrical potentials. The distancebetween the heart and ECG electrodes reduces the magnitude of electricalpotentials in proportion to the square of change in distance, whichcompounds the problem of sensing low amplitude P-waves. Moreover, thetissues and structures that lie between the activation regions withinthe heart and the body's surface alter the cardiac electrical field dueto changes in the electrical resistivity of adjacent tissues. Thus,surface electrical potentials, when even capable of being accuratelydetected, are smoothed over in aspect and bear only a general spatialrelationship to actual underlying cardiac events, thereby complicatingdiagnosis. Conventional 12-lead ECGs attempt to compensate for weakP-wave signals by monitoring the heart from multiple perspectives andangles, while conventional ambulatory ECGs primarily focus on monitoringhigher amplitude ventricular activity that can be readily sensed. Bothapproaches are unsatisfactory with respect to the P-wave and theaccurate, medically actionable diagnosis of the myriad cardiac rhythmdisorders that exist.

Additionally, maintaining continual contact between ECG electrodes andthe skin after a day or two of ambulatory ECG monitoring has been aproblem. Time, dirt, moisture, and other environmental contaminants, aswell as perspiration, skin oil, and dead skin cells from the patient'sbody, can get between an ECG electrode's non-conductive adhesive and theskin's surface. These factors adversely affect electrode adhesion andthe quality of cardiac signal recordings. Furthermore, the physicalmovements of the patient and their clothing impart variouscompressional, tensile, bending, and torsional forces on the contactpoint of an ECG electrode, especially over long recording times, and aninflexibly fastened ECG electrode will be prone to becoming dislodged.Moreover, dislodgment may occur unbeknownst to the patient, making theECG recordings worthless. Further, some patients may have skin that issusceptible to itching or irritation, and the wearing of ECG electrodescan aggravate such skin conditions. Thus, a patient may want or need toperiodically remove or replace ECG electrodes during a long-term ECGmonitoring period, whether to replace a dislodged electrode, reestablishbetter adhesion, alleviate itching or irritation, allow for cleansing ofthe skin, allow for showering and exercise, or for other purpose. Suchreplacement or slight alteration in electrode location actuallyfacilitates the goal of recording the ECG signal for long periods oftime.

Conventionally, multi-week or multi-month monitoring can be performed byimplantable ECG monitors, such as the Reveal LINQ insertable cardiacmonitor, manufactured by Medtronic, Inc., Minneapolis, Minn. Thismonitor can detect and record paroxysmal or asymptomatic arrhythmias forup to three years. However, like all forms of implantable medical device(IMD), use of this monitor requires invasive surgical implantation,which significantly increases costs; requires ongoing follow up by aphysician throughout the period of implantation; requires specializedequipment to retrieve monitoring data; and carries complicationsattendant to all surgery, including risks of infection, injury or death.

Holter monitors are widely used for extended ECG monitoring. Typically,they are often used for only 24-48 hours. A typical Holter monitor is awearable and portable version of an ECG that include cables for eachelectrode placed on the skin and a separate battery-powered ECGrecorder. The leads are placed in the anterior thoracic region in amanner similar to what is done with an in-clinic standard ECG machineusing electrode locations that are not specifically intended for optimalP-wave capture. The duration of monitoring depends on the sensing andstorage capabilities of the monitor. A “looping” Holter (or event)monitor can operate for a longer period of time by overwriting older ECGtracings, thence “recycling” storage in favor of extended operation, yetat the risk of losing event data. Although capable of extended ECGmonitoring, Holter monitors are cumbersome, expensive and typically onlyavailable by medical prescription, which limits their usability.Further, the skill required to properly place the electrodes on thepatient's chest precludes a patient from replacing or removing thesensing leads and usually involves moving the patient from the physicianoffice to a specialized center within the hospital or clinic.

U.S. Pat. No. 8,460,189, to Libbus et al. (“Libbus”) discloses anadherent wearable cardiac monitor that includes at least two measurementelectrodes and an accelerometer. The device includes a reusableelectronics module and a disposable adherent patch that includes theelectrodes. ECG monitoring can be conducted using multiple disposablepatches adhered to different locations on the patient's body. The deviceincludes a processor configured to control collection and transmissionof data from ECG circuitry, including generating and processing of ECGsignals and data acquired from two or more electrodes. The ECG circuitrycan be coupled to the electrodes in many ways to define an ECG vector,and the orientation of the ECG vector can be determined in response tothe polarity of the measurement electrodes and orientation of theelectrode measurement axis. The accelerometer can be used to determinethe orientation of the measurement electrodes in each of the locations.The ECG signals measured at different locations can be rotated based onthe accelerometer data to modify amplitude and direction of the ECGfeatures to approximate a standard ECG vector. The signals recorded atdifferent locations can be combined by summing a scaled version of eachsignal. Libbus further discloses that inner ECG electrodes may bepositioned near outer electrodes to increase the voltage of measured ECGsignals. However, Libbus treats ECG signal acquisition as themeasurement of a simple aggregate directional data signal withoutdifferentiating between the distinct kinds of cardiac electricalactivities presented with an ECG waveform, particularly atrial (P-wave)activity.

The ZIO XT Patch and ZIO Event Card devices, manufactured by iRhythmTech., Inc., San Francisco, Calif., are wearable monitoring devices thatare typically worn on the upper left pectoral region to respectivelyprovide continuous and looping ECG recording. The location is used tosimulate surgically implanted monitors, but without specificallyenhancing P-wave capture. Both of these devices are prescription-onlyand for single patient use. The ZIO XT Patch device is limited to a14-day period, while the electrodes only of the ZIO Event Card devicecan be worn for up to 30 days. The ZIO XT Patch device combines bothelectronic recordation components and physical electrodes into a unitaryassembly that adheres to the patient's skin. The ZIO XT Patch deviceuses adhesive sufficiently strong to support the weight of both themonitor and the electrodes over an extended period and to resistdisadherence from the patient's body, albeit at the cost of disallowingremoval or relocation during the monitoring period. The ZIO Event Carddevice is a form of downsized Holter monitor with a recorder componentthat must be removed temporarily during baths or other activities thatcould damage the non-waterproof electronics. Both devices representcompromises between length of wear and quality of ECG monitoring,especially with respect to ease of long term use, female-friendly fit,and quality of cardiac electrical potential signals, especially atrial(P-wave) signals.

Therefore, a need remains for a low cost extended wear continuouslyrecording ECG monitor attuned to capturing low amplitude cardiac actionpotential propagation for arrhythmia diagnosis, particularly atrialactivation P-waves, and practicably capable of being worn for a longperiod of time, especially in patient's whose breast anatomy or size caninterfere with signal quality in both women and men.

SUMMARY

Physiological monitoring can be provided through a lightweight wearablemonitor that includes two components, a flexible extended wear electrodepatch and a reusable monitor recorder that removably snaps into areceptacle on the electrode patch. The wearable monitor sits centrally(in the midline) on the patient's chest along the sternum orientedtop-to-bottom. The ECG electrodes on the electrode patch are tailored tobe positioned axially along the midline of the sternum for capturingaction potential propagation in an orientation that corresponds to theaVF lead used in a conventional 12-lead ECG that is used to sensepositive or upright P-waves. The placement of the wearable monitor in alocation at the sternal midline (or immediately to either side of thesternum), with its unique narrow “hourglass”-like shape, significantlyimproves the ability of the wearable monitor to cutaneously sensecardiac electrical potential signals, particularly the P-wave (or atrialactivity) and, to a lesser extent, the QRS interval signals indicatingventricular activity in the ECG waveforms. In addition, the monitorrecorder includes an ECG sensing circuit that measures raw cutaneouselectrical signals using a driven reference containing power supplynoise and system noise to the reference lead, which is critical topreserving the characteristics of low amplitude cardiac actionpotentials, particularly P-waves.

Moreover, the electrocardiography monitor offers superior patientcomfort, convenience and user-friendliness. The electrode patch isspecifically designed for ease of use by a patient (or caregiver);assistance by professional medical personnel is not required. Thepatient is free to replace the electrode patch at any time and need notwait for a doctor's appointment to have a new electrode patch placed.Patients can easily be taught to find the familiar physical landmarks onthe body necessary for proper placement of the electrode patch.Empowering patients with the knowledge to place the electrode patch inthe right place ensures that the ECG electrodes will be correctlypositioned on the skin, no matter the number of times that the electrodepatch is replaced. In addition, the monitor recorder operatesautomatically and the patient only need snap the monitor recorder intoplace on the electrode patch to initiate ECG monitoring. Thus, thesynergistic combination of the electrode patch and monitor recordermakes the use of the electrocardiography monitor a reliable andvirtually foolproof way to monitor a patient's ECG and physiology for anextended, or even open-ended, period of time.

In one embodiment, a monitor recorder optimized for electrocardiographicpotential processing is provided. The monitor recorder includes ahousing adapted to be coupled to at least one electrocardiographicelectrode and an electronic circuitry provided within the housing. Theelectronic circuitry includes an electrocardiographic front end circuitunder the control of a low-power microcontroller and configured to senseelectrocardiographic potentials through the at least oneelectrocardiographic electrode and to output electrocardiographicsignals representative of cardiac activation wave front amplitudes, theelectrocardiographic front end circuit comprising an operationalamplifier and an AC coupling capacitor through which a current of thesensed electrocardiographic potentials sequentially passes, wherein theoperational amplifier amplifies the current; the low-powermicrocontroller operable to execute over an extended period undermodular micro program control as specified in firmware and furtheroperable to acquire samples of the output electrocardiographic signals;and a non-volatile memory electrically interfaced with themicrocontroller and operable to continuously store the samples of theelectrocardiographic signals throughout the extended period.

A further embodiment provides monitor optimized for electrocardiographicpotential processing. The monitor includes a disposable extended wearelectrode patch and an electrocardiography monitor recorder. The patchincludes a flexible backing comprising stretchable material defined asan elongated strip with a narrow longitudinal midsection;

a pair of electrocardiographic electrodes included on the contactsurface of each end of the flexible backing, each electrocardiographicelectrode conductively exposed for dermal adhesion and adapted to bepositioned axially along a midline of a sternum for capturing actionpotential propagation; a non-conductive receptacle affixed to anon-contacting surface of the flexible backing and including an electromechanical docking interface; and a pair of flexible circuit tracesaffixed at each end of the flexible backing with each circuit traceconnecting one of the electrocardiographic electrodes to the dockinginterface.The recorder includes a wearable housing adapted to be coupled to a pairof electrocardiographic electrodes that are fitted for dermal placementalong the sternal midline and an electronic circuitry provided withinthe wearable housing.The electronic circuitry includes an electrocardiographic front endcircuit under the control of a low-power microcontroller and configuredto sense electrocardiographic potentials through theelectrocardiographic electrodes and to output electrocardiographicsignals representative of cardiac activation wave front amplitudes, theelectrocardiographic front end circuit comprising an operationalamplifier and an AC coupling capacitor through which a current of thesensed electrocardiographic potentials sequentially passes, wherein theoperational amplifier amplifies the current; the low-powermicrocontroller operable to execute over an extended period undermodular micro program control as specified in firmware and furtheroperable to acquire samples of the output electrocardiographic signals;and a non-volatile memory electrically interfaced with themicrocontroller and operable to continuously store the samples of theelectrocardiographic signals throughout the extended period.

The foregoing aspects enhance ECG monitoring performance and quality byfacilitating long-term ECG recording, which is critical to accuratearrhythmia and cardiac rhythm disorder diagnoses.

The monitoring patch is especially suited to the female anatomy,although also easily used over the male sternum. The narrow longitudinalmidsection can fit nicely within the inter-mammary cleft of the breastswithout inducing discomfort, whereas conventional patch electrodes arewide and, if adhered between the breasts, would cause chafing,irritation, discomfort, and annoyance, leading to low patientcompliance.

In addition, the foregoing aspects enhance comfort in women (and certainmen), but not irritation of the breasts, by placing the monitoring patchin the best location possible for optimizing the recording of cardiacsignals from the atrium, particularly P-waves, which is another featurecritical to proper arrhythmia and cardiac rhythm disorder diagnoses.

Still other embodiments will become readily apparent to those skilled inthe art from the following detailed description, wherein are describedembodiments by way of illustrating the best mode contemplated. As willbe realized, other and different embodiments are possible and theembodiments' several details are capable of modifications in variousobvious respects, all without departing from their spirit and the scope.Accordingly, the drawings and detailed description are to be regarded asillustrative in nature and not as restrictive.

BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1 and 2 are diagrams showing, by way of examples, an extended wearelectrocardiography monitor, including an extended wear electrode patch,in accordance with one embodiment, respectively fitted to the sternalregion of a female patient and a male patient.

FIG. 3 is a front anatomical view showing, by way of illustration, thelocations of the heart and lungs within the rib cage of an adult human.

FIG. 4 is a perspective view showing an extended wear electrode patch inaccordance with one embodiment with a monitor recorder inserted.

FIG. 5 is a perspective view showing the monitor recorder of FIG. 4.

FIG. 6 is a perspective view showing the extended wear electrode patchof FIG. 4 without a monitor recorder inserted.

FIG. 7 is a bottom plan view of the monitor recorder of FIG. 4.

FIG. 8 is a top view showing the flexible circuit of the extended wearelectrode patch of FIG. 4.

FIG. 9 is a functional block diagram showing the component architectureof the circuitry of the monitor recorder of FIG. 4.

FIG. 10 is a functional block diagram showing the circuitry of theextended wear electrode patch of FIG. 4.

FIG. 11 is a schematic diagram showing the ECG front end circuit of thecircuitry of the monitor recorder of FIG. 9.

FIG. 12 is a flow diagram showing a monitor recorder-implemented methodfor monitoring ECG data for use in the monitor recorder of FIG. 4.

FIG. 13 is a graph showing, by way of example, a typical ECG waveform.

FIG. 14 is a functional block diagram showing the signal processingfunctionality of the microcontroller.

FIG. 15 is a functional block diagram showing the operations performedby the download station.

FIGS. 16A-C are functional block diagrams respectively showing practicaluses of the extended wear electrocardiography monitors of FIGS. 1 and 2.

FIG. 17 is a perspective view of an extended wear electrode patch with aflexile wire electrode assembly in accordance with a still furtherembodiment.

FIG. 18 is perspective view of the flexile wire electrode assembly fromFIG. 17, with a layer of insulating material shielding a bare distalwire around the midsection of the flexible backing.

FIG. 19 is a bottom view of the flexile wire electrode assembly as shownin FIG. 17.

FIG. 20 is a bottom view of a flexile wire electrode assembly inaccordance with a still yet further embodiment.

FIG. 21 is a perspective view showing the longitudinal midsection of theflexible backing of the electrode assembly from FIG. 17.

DETAILED DESCRIPTION

ECG and physiological monitoring can be provided through a wearableambulatory monitor that includes two components, a flexible extendedwear electrode patch and a removable reusable (or single use) monitorrecorder. Both the electrode patch and the monitor recorder areoptimized to capture electrical signals from the propagation of lowamplitude, relatively low frequency content cardiac action potentials,particularly the P-waves generated during atrial activation. FIGS. 1 and2 are diagrams showing, by way of examples, an extended wearelectrocardiography monitor 12, including a monitor recorder 14, inaccordance with one embodiment, respectively fitted to the sternalregion of a female patient 10 and a male patient 11. The wearablemonitor 12 sits centrally, positioned axially along the sternal midline16, on the patient's chest along the sternum 13 and orientedtop-to-bottom with the monitor recorder 14 preferably situated towardsthe patient's head. In a further embodiment, the orientation of thewearable monitor 12 can be corrected post-monitoring, as furtherdescribed infra, for instance, if the wearable monitor 12 isinadvertently fitted upside down.

The electrode patch 15 is shaped to fit comfortably and conformal to thecontours of the patient's chest approximately centered on the sternalmidline 16 (or immediately to either side of the sternum 13). The distalend of the electrode patch 15, under which a lower or inferior pole (ECGelectrode) is adhered, extends towards the Xiphoid process and lowersternum and, depending upon the patient's build, may straddle the regionover the Xiphoid process and lower sternum. The proximal end of theelectrode patch 15, located under the monitor recorder 14, under whichan upper or superior pole (ECG electrode) is adhered, is below themanubrium and, depending upon patient's build, may straddle the regionover the manubrium.

During ECG monitoring, the amplitude and strength of action potentialssensed on the body's surface are affected to varying degrees by cardiac,cellular, extracellular, vector of current flow, and physical factors,like obesity, dermatitis, large breasts, and high impedance skin, as canoccur in dark-skinned individuals. Sensing along the sternal midline 16(or immediately to either side of the sternum 13) significantly improvesthe ability of the wearable monitor 12 to cutaneously sense cardiacelectric signals, particularly the P-wave (or atrial activity) and, to alesser extent, the QRS interval signals in the ECG waveforms thatindicate ventricular activity by countering some of the effects of thesefactors.

The ability to sense low amplitude, low frequency content body surfacepotentials is directly related to the location of ECG electrodes on theskin's surface and the ability of the sensing circuitry to capture theseelectrical signals. FIG. 3 is a front anatomical view showing, by way ofillustration, the locations of the heart 4 and lungs 5 within the ribcage of an adult human. Depending upon their placement locations on thechest, ECG electrodes may be separated from activation regions withinthe heart 4 by differing combinations of internal tissues and bodystructures, including heart muscle, intracardiac blood, the pericardium,intrathoracic blood and fluids, the lungs 5, skeletal muscle, bonestructure, subcutaneous fat, and the skin, plus any contaminants presentbetween the skin's surface and electrode signal pickups. The degree ofamplitude degradation of cardiac transmembrane potentials increases withthe number of tissue boundaries between the heart 4 and the skin'ssurface that are encountered. The cardiac electrical field is degradedeach time the transmembrane potentials encounter a physical boundaryseparating adjoining tissues due to differences in the respectivetissues' electrical resistances. In addition, other non-spatial factors,such as pericardial effusion, emphysema or fluid accumulation in thelungs, as further explained infra, can further degrade body surfacepotentials.

Internal tissues and body structures can adversely affect the currentstrength and signal fidelity of all body surface potentials, yet lowamplitude cardiac action potentials, particularly the P-wave with anormative amplitude of less than 0.25 microvolts (mV) and a normativeduration of less than 120 milliseconds (ms), are most apt to benegatively impacted. The atria 6 are generally located posteriorlywithin the thoracic cavity (with the exception of the anterior rightatrium and right atrial appendage), and, physically, the left atriumconstitutes the portion of the heart 4 furthest away from the surface ofthe skin on the chest. Conversely, the ventricles 7, which generatelarger amplitude signals, generally are located anteriorly with theanterior right ventricle and most of the left ventricle situatedrelatively close to the skin surface on the chest, which contributes tothe relatively stronger amplitudes of ventricular waveforms. Thus, thequality of P-waves (and other already-low amplitude action potentialsignals) is more susceptible to weakening from intervening tissues andstructures than the waveforms associated with ventricular activation.

The importance of the positioning of ECG electrodes along the sternalmidline 15 has largely been overlooked by conventional approaches to ECGmonitoring, in part due to the inability of their sensing circuitry toreliably detect low amplitude, low frequency content electrical signals,particularly in P-waves. In turn, that inability to keenly sense P-waveshas motivated ECG electrode placement in other non-sternal midlinethoracic locations, where the QRSTU components that representventricular electrical activity are more readily detectable by theirsensing circuitry than P-waves. In addition, ECG electrode placementalong the sternal midline 15 presents major patient wearabilitychallenges, such as fitting a monitoring ensemble within the narrowconfines of the inter-mammary cleft between the breasts, that to largeextent drive physical packaging concerns, which can be incompatible withECG monitors intended for placement, say, in the upper pectoral regionor other non-sternal midline thoracic locations. In contrast, thewearable monitor 12 uses an electrode patch 15 that is specificallyintended for extended wear placement in a location at the sternalmidline 16 (or immediately to either side of the sternum 13). Whencombined with a monitor recorder 14 that uses sensing circuitryoptimized to preserve the characteristics of low amplitude cardiacaction potentials, especially those signals from the atria, as furtherdescribed infra with reference to FIG. 11, the electrode patch 15 helpsto significantly improve atrial activation (P-wave) sensing throughplacement in a body location that robustly minimizes the effects oftissue and body structure.

Referring back to FIGS. 1 and 2, the placement of the wearable monitor12 in the region of the sternal midline 13 puts the ECG electrodes ofthe electrode patch 15 in locations better adapted to sensing andrecording low amplitude cardiac action potentials during atrialpropagation (P-wave signals) than placement in other locations, such asthe upper left pectoral region, as commonly seen in most conventionalambulatory ECG monitors. The sternum 13 overlies the right atrium of theheart 4. As a result, action potential signals have to travel throughfewer layers of tissue and structure to reach the ECG electrodes of theelectrode patch 15 on the body's surface along the sternal midline 13when compared to other monitoring locations, a distinction that is ofcritical importance when capturing low frequency content electricalsignals, such as P-waves.

Moreover, cardiac action potential propagation travels simultaneouslyalong a north-to-south and right-to-left vector, beginning high in theright atrium and ultimately ending in the posterior and lateral regionof the left ventricle. Cardiac depolarization originates high in theright atrium in the SA node before concurrently spreading leftwardtowards the left atrium and inferiorly towards the AV node. The ECGelectrodes of the electrode patch 15 are placed with the upper orsuperior pole (ECG electrode) along the sternal midline 13 in the regionof the manubrium and the lower or inferior pole (ECG electrode) alongthe sternal midline 13 in the region of the Xiphoid process 9 and lowersternum. The ECG electrodes are placed primarily in a north-to-southorientation along the sternum 13 that corresponds to the north-to-southwaveform vector exhibited during atrial activation. This orientationcorresponds to the aVF lead used in a conventional 12-lead ECG that isused to sense positive or upright P-waves.

Furthermore, the thoracic region underlying the sternum 13 along themidline 16 between the manubrium 8 and Xiphoid process 9 is relativelyfree of lung tissue, musculature, and other internal body structuresthat could occlude the electrical signal path between the heart 4,particularly the atria, and ECG electrodes placed on the surface of theskin. Fewer obstructions means that cardiac electrical potentialsencounter fewer boundaries between different tissues. As a result, whencompared to other thoracic ECG sensing locations, the cardiac electricalfield is less altered when sensed dermally along the sternal midline 13.As well, the proximity of the sternal midline 16 to the ventricles 7facilitates sensing of right ventricular activity and provides superiorrecordation of the QRS interval, again, in part due to the relativelyclear electrical path between the heart 4 and the skin surface.

Finally, non-spatial factors can affect transmembrane action potentialshape and conductivity. For instance, myocardial ischemia, an acutecardiac condition, can cause a transient increase in blood perfusion inthe lungs 5. The perfused blood can significantly increase electricalresistance across the lungs 5 and therefore degrade transmission of thecardiac electrical field to the skin's surface. However, the placementof the wearable monitor 12 along the sternal midline 16 in theinter-mammary cleft between the breasts is relatively resilient to theadverse effects to cardiac action potential degradation caused byischemic conditions as the body surface potentials from a locationrelatively clear of underlying lung tissue and fat help compensate forthe loss of signal amplitude and content. The monitor recorder 14 isthus able to record the P-wave morphology that may be compromised bymyocardial ischemia and therefore make diagnosis of the specificarrhythmias that can be associated with myocardial ischemia moredifficult.

During use, the electrode patch 15 is first adhered to the skin alongthe sternal midline 16 (or immediately to either side of the sternum13). A monitor recorder 14 is then snapped into place on the electrodepatch 15 using an electro mechanical docking interface to initiate ECGmonitoring. FIG. 4 is a perspective view showing an extended wearelectrode patch 15 in accordance with one embodiment with a monitorrecorder 14 inserted. The body of the electrode patch 15 is preferablyconstructed using a flexible backing 20 formed as an elongated strip 21of wrap knit or similar stretchable material about 145 mm long and 32 mmat the widest point with a narrow longitudinal mid-section 23 evenlytapering inward from both sides. A pair of cut-outs 22 between thedistal and proximal ends of the electrode patch 15 create a narrowlongitudinal midsection 23 or “isthmus” and defines an elongated“hourglass”-like shape, when viewed from above, such as described incommonly-assigned U.S. Design Pat. No. D744,659, issued Dec. 1, 2015,the disclosure of which is incorporated by reference. The upper part ofthe “hourglass” is sized to allow an electrically non-conductivereceptacle 25, sits on top of the outward-facing surface of theelectrode patch 15, to be affixed to the electrode patch 15 with an ECGelectrode placed underneath on the patient-facing underside, or contact,surface of the electrode patch 15; the upper part of the “hourglass” hasa longer and wider profile (but still rounded and tapered to fitcomfortably between the breasts) than the lower part of the “hourglass,”which is sized primarily to allow just the placement of an ECG electrodeof appropriate shape and surface area to record the P-wave and the QRSsignals sufficiently given the inter-electrode spacing.

The electrode patch 15 incorporates features that significantly improvewearability, performance, and patient comfort throughout an extendedmonitoring period. The entire electrode patch 15 is lightweight inconstruction, which allows the patch to be resilient to disadhesing orfalling off and, critically, to avoid creating distracting discomfort tothe patient, even when the patient is asleep. In contrast, the weight ofa heavy ECG monitor impedes patient mobility and will cause the monitorto constantly tug downwards and press on the patient's body that cangenerate skin inflammation with frequent adjustments by the patientneeded to maintain comfort.

During everyday wear, the electrode patch 15 is subjected to pushing,pulling, and torsional movements, including compressional and torsionalforces when the patient bends forward, or tensile and torsional forceswhen the patient leans backwards. To counter these stress forces, theelectrode patch 15 incorporates crimp and strain reliefs, such asdescribed in commonly-assigned U.S. Pat. No. 9,545,204, issued Jan. 17,2017, the disclosure of which is incorporated by reference. In addition,the cut-outs 22 and longitudinal midsection 23 help minimizeinterference with and discomfort to breast tissue, particularly in women(and gynecomastic men). The cut-outs 22 and longitudinal midsection 23further allow better conformity of the electrode patch 15 to sternalbowing and to the narrow isthmus of flat skin that can occur along thebottom of the inter-mammary cleft between the breasts, especially inbuxom women. The cut-outs 22 and narrow and flexible longitudinalmidsection 23 help the electrode patch 15 fit nicely between a pair offemale breasts in the inter-mammary cleft. In one embodiment, thecut-outs 22 can be graduated to form the longitudinal midsection 23 as anarrow in-between stem or isthmus portion about 7 mm wide. In a stillfurther embodiment, tabs 24 can respectively extend an additional 8 mmto 12 mm beyond the distal and proximal ends of the flexible backing 20to facilitate with adhering the electrode patch 15 to or removing theelectrode patch 15 from the sternum 13. These tabs preferably lackadhesive on the underside, or contact, surface of the electrode patch15. Still other shapes, cut-outs and conformities to the electrode patch15 are possible.

The monitor recorder 14 removably and reusably snaps into anelectrically non-conductive receptacle 25 during use. The monitorrecorder 14 contains electronic circuitry for recording and storing thepatient's electrocardiography as sensed via a pair of ECG electrodesprovided on the electrode patch 15, as further described infra beginningwith reference to FIG. 9. The non-conductive receptacle 25 is providedon the top surface of the flexible backing 20 with a retention catch 26and tension clip 27 molded into the non-conductive receptacle 25 toconformably receive and securely hold the monitor recorder 14 in place.

The monitor recorder 14 includes a sealed housing that snaps into placein the non-conductive receptacle 25. FIG. 5 is a perspective viewshowing the monitor recorder 14 of FIG. 4. The sealed housing 50 of themonitor recorder 14 intentionally has a rounded isoscelestrapezoidal-like shape 52, when viewed from above, such as described incommonly-assigned U.S. Design Pat. No. D717,955, issued Nov. 18, 2014,the disclosure of which is incorporated by reference. The edges 51 alongthe top and bottom surfaces are rounded for patient comfort. The sealedhousing 50 is approximately 47 mm long, 23 mm wide at the widest point,and 7 mm high, excluding a patient-operable tactile-feedback button 55.The sealed housing 50 can be molded out of polycarbonate, ABS, or analloy of those two materials. The button 55 is waterproof and thebutton's top outer surface is molded silicon rubber or similar softpliable material. A retention detent 53 and tension detent 54 are moldedalong the edges of the top surface of the housing 50 to respectivelyengage the retention catch 26 and the tension clip 27 molded intonon-conductive receptacle 25. Other shapes, features, and conformitiesof the sealed housing 50 are possible.

The electrode patch 15 is intended to be disposable, while the monitorrecorder 14 is designed for reuse and can be transferred to successiveelectrode patches 15 to ensure continuity of monitoring, if so desired.The monitor recorder 14 can be used only once, but single useeffectively wastes the synergistic benefits provided by the combinationof the disposable electrode patch and reusable monitor recorder, asfurther explained infra with reference to FIGS. 16A-C. The placement ofthe wearable monitor 12 in a location at the sternal midline 16 (orimmediately to either side of the sternum 13) benefits long-termextended wear by removing the requirement that ECG electrodes becontinually placed in the same spots on the skin throughout themonitoring period. Instead, the patient is free to place an electrodepatch 15 anywhere within the general region of the sternum 13.

As a result, at any point during ECG monitoring, the patient's skin isable to recover from the wearing of an electrode patch 15, whichincreases patient comfort and satisfaction, while the monitor recorder14 ensures ECG monitoring continuity with minimal effort. A monitorrecorder 14 is merely unsnapped from a worn out electrode patch 15, theworn out electrode patch 15 is removed from the skin, a new electrodepatch 15 is adhered to the skin, possibly in a new spot immediatelyadjacent to the earlier location, and the same monitor recorder 14 issnapped into the new electrode patch 15 to reinitiate and continue theECG monitoring.

During use, the electrode patch 15 is first adhered to the skin in thesternal region. FIG. 6 is a perspective view showing the extended wearelectrode patch 15 of FIG. 4 without a monitor recorder 14 inserted. Aflexible circuit 32 is adhered to each end of the flexible backing 20. Adistal circuit trace 33 from the distal end 30 of the flexible backing20 and a proximal circuit trace (not shown) from the proximal end 31 ofthe flexible backing 20 electrically couple ECG electrodes (not shown)with a pair of electrical pads 34. In a further embodiment, the distaland proximal circuit traces are replaced with interlaced or sewn-inflexible wires, as further described infra beginning with reference toFIG. 17. The electrical pads 34 are provided within a moisture-resistantseal 35 formed on the bottom surface of the non-conductive receptacle25. When the monitor recorder 14 is securely received into thenon-conductive receptacle 25, that is, snapped into place, theelectrical pads 34 interface to electrical contacts (not shown)protruding from the bottom surface of the monitor recorder 14. Themoisture-resistant seal 35 enables the monitor recorder 14 to be worn atall times, even during showering or other activities that could exposethe monitor recorder 14 to moisture or adverse conditions.

In addition, a battery compartment 36 is formed on the bottom surface ofthe non-conductive receptacle 25. A pair of battery leads (not shown)from the battery compartment 36 to another pair of the electrical pads34 electrically interface the battery to the monitor recorder 14. Thebattery contained within the battery compartment 35 is a direct current(DC) power cell and can be replaceable, rechargeable or disposable.

The monitor recorder 14 draws power externally from the battery providedin the non-conductive receptacle 25, thereby uniquely obviating the needfor the monitor recorder 14 to carry a dedicated power source. FIG. 7 isa bottom plan view of the monitor recorder 14 of FIG. 4. A cavity 58 isformed on the bottom surface of the sealed housing 50 to accommodate theupward projection of the battery compartment 36 from the bottom surfaceof the non-conductive receptacle 25, when the monitor recorder 14 issecured in place on the non-conductive receptacle 25. A set ofelectrical contacts 56 protrude from the bottom surface of the sealedhousing 50 and are arranged in alignment with the electrical pads 34provided on the bottom surface of the non-conductive receptacle 25 toestablish electrical connections between the electrode patch 15 and themonitor recorder 14. In addition, a seal coupling 57 circumferentiallysurrounds the set of electrical contacts 56 and securely mates with themoisture-resistant seal 35 formed on the bottom surface of thenon-conductive receptacle 25. The battery contained within the batterycompartment 36 can be replaceable, rechargeable or disposable. In afurther embodiment, the ECG sensing circuitry of the monitor recorder 14can be supplemented with additional sensors, including an SpO₂ sensor, ablood pressure sensor, a temperature sensor, respiratory rate sensor, aglucose sensor, an air flow sensor, and a volumetric pressure sensor,which can be incorporated directly into the monitor recorder 14 or ontothe non-conductive receptacle 25.

The placement of the flexible backing 20 on the sternal midline 16 (orimmediately to either side of the sternum 13) also helps to minimize theside-to-side movement of the wearable monitor 12 in the left- andright-handed directions during wear. However, the wearable monitor 12 isstill susceptible to pushing, pulling, and torqueing movements,including compressional and torsional forces when the patient bendsforward, and tensile and torsional forces when the patient leansbackwards or twists. To counter the dislodgment of the flexible backing20 due to compressional and torsional forces, a layer of non-irritatingadhesive, such as hydrocolloid, is provided at least partially on theunderside, or contact, surface of the flexible backing 20, but only onthe distal end 30 and the proximal end 31. As a result, the underside,or contact surface of the longitudinal midsection 23 does not have anadhesive layer and remains free to move relative to the skin. Thus, thelongitudinal midsection 23 forms a crimp relief that respectivelyfacilitates compression and twisting of the flexible backing 20 inresponse to compressional and torsional forces. Other forms of flexiblebacking crimp reliefs are possible.

Unlike the flexible backing 20, the flexible circuit 32 is only able tobend and cannot stretch in a planar direction. The flexible circuit 32can be provided either above or below the flexible backing 20. FIG. 8 isa top view showing the flexible circuit 32 of the extended wearelectrode patch 15 of FIG. 4 when mounted above the flexible backing 20.A distal ECG electrode 38 and proximal ECG electrode 39 are respectivelycoupled to the distal and proximal ends of the flexible circuit 32 toserve as electrode signal pickups. The flexible circuit 32 preferablydoes not extend to the outside edges of the flexible backing 20, therebyavoiding gouging or discomforting the patient's skin during extendedwear, such as when sleeping on the side. During wear, the ECG electrodes38, 39 must remain in continual contact with the skin. A strain relief40 is defined in the flexible circuit 32 at a location that is partiallyunderneath the battery compartment 36 when the flexible circuit 32 isaffixed to the flexible backing 20. The strain relief 40 is laterallyextendable to counter dislodgment of the ECG electrodes 38, 39 due tobending, tensile and torsional forces. A pair of strain relief cutouts41 partially extend transversely from each opposite side of the flexiblecircuit 32 and continue longitudinally towards each other to define in‘S’-shaped pattern, when viewed from above. The strain reliefrespectively facilitates longitudinal extension and twisting of theflexible circuit 32 in response to tensile and torsional forces. Otherforms of circuit board strain relief are possible.

ECG monitoring and other functions performed by the monitor recorder 14are provided through a micro controlled architecture. FIG. 9 is afunctional block diagram showing the component architecture of thecircuitry 60 of the monitor recorder 14 of FIG. 4. The circuitry 60 isexternally powered through a battery provided in the non-conductivereceptacle 25 (shown in FIG. 6). Both power and raw ECG signals, whichoriginate in the pair of ECG electrodes 38, 39 (shown in FIG. 8) on thedistal and proximal ends of the electrode patch 15, are received throughan external connector 65 that mates with a corresponding physicalconnector on the electrode patch 15. The external connector 65 includesthe set of electrical contacts 56 that protrude from the bottom surfaceof the sealed housing 50 and which physically and electrically interfacewith the set of pads 34 provided on the bottom surface of thenon-conductive receptacle 25. The external connector includes electricalcontacts 56 for data download, microcontroller communications, power,analog inputs, and a peripheral expansion port. The arrangement of thepins on the electrical connector 65 of the monitor recorder 14 and thedevice into which the monitor recorder 14 is attached, whether anelectrode patch 15 or download station (not shown), follow the sameelectrical pin assignment convention to facilitate interoperability. Theexternal connector 65 also serves as a physical interface to a downloadstation that permits the retrieval of stored ECG monitoring data,communication with the monitor recorder 14, and performance of otherfunctions. The download station is further described infra withreference to FIG. 15.

Operation of the circuitry 60 of the monitor recorder 14 is managed by amicrocontroller 61, such as the EFM32 Tiny Gecko 32-bit microcontroller,manufactured by Silicon Laboratories Inc., Austin, Tex. Themicrocontroller 61 has flexible energy management modes and includes adirect memory access controller and built-in analog-to-digital anddigital-to-analog converters (ADC and DAC, respectively). Themicrocontroller 61 also includes a program memory unit containinginternal flash memory that is readable and writeable. The internal flashmemory can also be programmed externally. The microcontroller 61operates under modular micro program control as specified in firmwarestored in the internal flash memory. The functionality and firmwaremodules relating to signal processing by the microcontroller 61 arefurther described infra with reference to FIG. 14. The microcontroller61 draws power externally from the battery provided on the electrodepatch 15 via a pair of the electrical contacts 56. The microcontroller61 connects to the ECG front end circuit 63 that measures raw cutaneouselectrical signals using a driven reference that eliminates common modenoise, as further described infra with reference to FIG. 11.

The circuitry 60 of the monitor recorder 14 also includes a flash memory62, which the microcontroller 61 uses for storing ECG monitoring dataand other physiology and information. The flash memory 62 also drawspower externally from the battery provided on the electrode patch 15 viaa pair of the electrical contacts 56. Data is stored in a serial flashmemory circuit, which supports read, erase and program operations over acommunications bus. The flash memory 62 enables the microcontroller 61to store digitized ECG data. The communications bus further enables theflash memory 62 to be directly accessed externally over the externalconnector 65 when the monitor recorder 14 is interfaced to a downloadstation.

The microcontroller 61 includes functionality that enables theacquisition of samples of analog ECG signals, which are converted into adigital representation, as further described infra with reference toFIG. 14. In one mode, the microcontroller 61 will acquire, sample,digitize, signal process, and store digitized ECG data into availablestorage locations in the flash memory 62 until all memory storagelocations are filled, after which the digitized ECG data needs to bedownloaded or erased to restore memory capacity. Data download orerasure can also occur before all storage locations are filled, whichwould free up memory space sooner, albeit at the cost of possiblyinterrupting monitoring while downloading or erasure is performed. Inanother mode, the microcontroller 61 can include a loop recorder featurethat will overwrite the oldest stored data once all storage locationsare filled, albeit at the cost of potentially losing the stored datathat was overwritten, if not previously downloaded. Still other modes ofdata storage and capacity recovery are possible.

The circuitry 60 of the monitor recorder 14 further includes anactigraphy sensor 64 implemented as a 3-axis accelerometer. Theaccelerometer may be configured to generate interrupt signals to themicrocontroller 61 by independent initial wake up and free fall events,as well as by device position. In addition, the actigraphy provided bythe accelerometer can be used during post-monitoring analysis to correctthe orientation of the monitor recorder 14 if, for instance, the monitorrecorder 14 has been inadvertently installed upside down, that is, withthe monitor recorder 14 oriented on the electrode patch 15 towards thepatient's feet, as well as for other event occurrence analyses.

The microcontroller 61 includes an expansion port that also utilizes thecommunications bus. External devices, separately drawing powerexternally from the battery provided on the electrode patch 15 or othersource, can interface to the microcontroller 61 over the expansion portin half duplex mode. For instance, an external physiology sensor can beprovided as part of the circuitry 60 of the monitor recorder 14, or canbe provided on the electrode patch 15 with communication with themicrocontroller 61 provided over one of the electrical contacts 56. Thephysiology sensor can include an SpO₂ sensor, blood pressure sensor,temperature sensor, respiratory rate sensor, glucose sensor, airflowsensor, volumetric pressure sensing, or other types of sensor ortelemetric input sources. In a further embodiment, a wireless interfacefor interfacing with other wearable (or implantable) physiologymonitors, as well as data offload and programming, can be provided aspart of the circuitry 60 of the monitor recorder 14, or can be providedon the electrode patch 15 with communication with the microcontroller 61provided over one of the electrical contacts 56.

Finally, the circuitry 60 of the monitor recorder 14 includespatient-interfaceable components, including a tactile feedback button66, which a patient can press to mark events or to perform otherfunctions, and a buzzer 67, such as a speaker, magnetic resonator orpiezoelectric buzzer. The buzzer 67 can be used by the microcontroller61 to output feedback to a patient such as to confirm power up andinitiation of ECG monitoring. Still other components as part of thecircuitry 60 of the monitor recorder 14 are possible.

While the monitor recorder 14 operates under micro control, most of theelectrical components of the electrode patch 15 operate passively. FIG.10 is a functional block diagram showing the circuitry 70 of theextended wear electrode patch 15 of FIG. 4. The circuitry 70 of theelectrode patch 15 is electrically coupled with the circuitry 60 of themonitor recorder 14 through an external connector 74. The externalconnector 74 is terminated through the set of pads 34 provided on thebottom of the non-conductive receptacle 25, which electrically mate tocorresponding electrical contacts 56 protruding from the bottom surfaceof the sealed housing 50 to electrically interface the monitor recorder14 to the electrode patch 15.

The circuitry 70 of the electrode patch 15 performs three primaryfunctions. First, a battery 71 is provided in a battery compartmentformed on the bottom surface of the non-conductive receptacle 25. Thebattery 71 is electrically interfaced to the circuitry 60 of the monitorrecorder 14 as a source of external power. The unique provisioning ofthe battery 71 on the electrode patch 15 provides several advantages.First, the locating of the battery 71 physically on the electrode patch15 lowers the center of gravity of the overall wearable monitor 12 andthereby helps to minimize shear forces and the effects of movements ofthe patient and clothing. Moreover, the housing 50 of the monitorrecorder 14 is sealed against moisture and providing power externallyavoids having to either periodically open the housing 50 for the batteryreplacement, which also creates the potential for moisture intrusion andhuman error, or to recharge the battery, which can potentially take themonitor recorder 14 off line for hours at a time. In addition, theelectrode patch 15 is intended to be disposable, while the monitorrecorder 14 is a reusable component. Each time that the electrode patch15 is replaced, a fresh battery is provided for the use of the monitorrecorder 14, which enhances ECG monitoring performance quality andduration of use. Also, the architecture of the monitor recorder 14 isopen, in that other physiology sensors or components can be added byvirtue of the expansion port of the microcontroller 61. Requiring thoseadditional sensors or components to draw power from a source external tothe monitor recorder 14 keeps power considerations independent of themonitor recorder 14. This approach also enables a battery of highercapacity to be introduced when needed to support the additional sensorsor components without effecting the monitor recorders circuitry 60.

Second, the pair of ECG electrodes 38, 39 respectively provided on thedistal and proximal ends of the flexible circuit 32 are electricallycoupled to the set of pads 34 provided on the bottom of thenon-conductive receptacle 25 by way of their respective circuit traces33, 37. The signal ECG electrode 39 includes a protection circuit 72,which is an inline resistor that protects the patient from excessiveleakage current should the front end circuit fail.

Last, in a further embodiment, the circuitry 70 of the electrode patch15 includes a cryptographic circuit 73 to authenticate an electrodepatch 15 for use with a monitor recorder 14. The cryptographic circuit73 includes a device capable of secure authentication and validation.The cryptographic device 73 ensures that only genuine, non-expired,safe, and authenticated electrode patches 15 are permitted to providemonitoring data to a monitor recorder 14 and for a specific patient.

The ECG front end circuit 63 measures raw cutaneous electrical signalsusing a driven reference that effectively reduces common mode noise,power supply noise and system noise, which is critical to preserving thecharacteristics of low amplitude cardiac action potentials, especiallythose signals from the atria. FIG. 11 is a schematic diagram 80 showingthe ECG front end circuit 63 of the circuitry 60 of the monitor recorder14 of FIG. 9. The ECG front end circuit 63 senses body surfacepotentials through a signal lead (“S1”) and reference lead (“REF”) thatare respectively connected to the ECG electrodes of the electrode patch15. Power is provided to the ECG front end circuit 63 through a pair ofDC power leads (“VCC” and “GND”). An analog ECG signal (“ECG”)representative of the electrical activity of the patient's heart overtime is output, which the micro controller 11 converts to digitalrepresentation and filters, as further described infra.

The ECG front end circuit 63 is organized into five stages, a passiveinput filter stage 81, a unity gain voltage follower stage 82, a passivehigh pass filtering stage 83, a voltage amplification and activefiltering stage 84, and an anti-aliasing passive filter stage 85, plus areference generator. Each of these stages and the reference generatorwill now be described.

The passive input filter stage 81 includes the parasitic impedance ofthe ECG electrodes 38, 39 (shown in FIG. 8), the protection resistorthat is included as part of the protection circuit 72 of the ECGelectrode 39 (shown in FIG. 10), an AC coupling capacitor 87, atermination resistor 88, and filter capacitor 89. This stage passivelyshifts the frequency response poles downward there is a high electrodeimpedance from the patient on the signal lead S1 and reference lead REF,which reduces high frequency noise.

The unity gain voltage follower stage 82 provides a unity voltage gainthat allows current amplification by an Operational Amplifier (“Op Amp”)90. In this stage, the voltage stays the same as the input, but morecurrent is available to feed additional stages. This configurationallows a very high input impedance, so as not to disrupt the bodysurface potentials or the filtering effect of the previous stage.

The passive high pass filtering stage 83 is a high pass filter thatremoves baseline wander and any offset generated from the previousstage. Adding an AC coupling capacitor 91 after the Op Amp 90 allows theuse of lower cost components, while increasing signal fidelity.

The voltage amplification and active filtering stage 84 amplifies thevoltage of the input signal through Op Amp 91, while applying a low passfilter. The DC bias of the input signal is automatically centered in thehighest performance input region of the Op Amp 91 because of the ACcoupling capacitor 91.

The anti-aliasing passive filter stage 85 provides an anti-aliasing lowpass filter. When the microcontroller 61 acquires a sample of the analoginput signal, a disruption in the signal occurs as a sample and holdcapacitor that is internal to the microcontroller 61 is charged tosupply signal for acquisition.

The reference generator in subcircuit 86 drives a driven referencecontaining power supply noise and system noise to the reference leadREF. A coupling capacitor 87 is included on the signal lead S1 and apair of resistors 93 a, 93 b inject system noise into the reference leadREF. The reference generator is connected directly to the patient,thereby avoiding the thermal noise of the protection resistor that isincluded as part of the protection circuit 72.

In contrast, conventional ECG lead configurations try to balance signaland reference lead connections. The conventional approach suffers fromthe introduction of differential thermal noise, lower input common moderejection, increased power supply noise, increased system noise, anddifferential voltages between the patient reference and the referenceused on the device that can obscure, at times, extremely, low amplitudebody surface potentials.

Here, the parasitic impedance of the ECG electrodes 38, 39, theprotection resistor that is included as part of the protection circuit72 and the coupling capacitor 87 allow the reference lead REF to beconnected directly to the skin's surface without any further components.As a result, the differential thermal noise problem caused by pairingprotection resistors to signal and reference leads, as used inconventional approaches, is avoided.

The monitor recorder 14 continuously monitors the patient's heart rateand physiology. FIG. 12 is a flow diagram showing a monitorrecorder-implemented method 100 for monitoring ECG data for use in themonitor recorder 14 of FIG. 4. Initially, upon being connected to theset of pads 34 provided with the non-conductive receptacle 25 when themonitor recorder 14 is snapped into place, the microcontroller 61executes a power up sequence (step 101). During the power up sequence,the voltage of the battery 71 is checked, the state of the flash memory62 is confirmed, both in terms of operability check and availablecapacity, and microcontroller operation is diagnostically confirmed. Ina further embodiment, an authentication procedure between themicrocontroller 61 and the electrode patch 15 are also performed.

Following satisfactory completion of the power up sequence, an iterativeprocessing loop (steps 102-110) is continually executed by themicrocontroller 61. During each iteration (step 102) of the processingloop, the ECG frontend 63 (shown in FIG. 9) continually senses thecutaneous ECG electrical signals (step 103) via the ECG electrodes 38,29 and is optimized to maintain the integrity of the P-wave. A sample ofthe ECG signal is read (step 104) by the microcontroller 61 by samplingthe analog ECG signal that is output by the ECG front end circuit 63.FIG. 13 is a graph showing, by way of example, a typical ECG waveform120. The x-axis represents time in approximate units of tenths of asecond. The y-axis represents cutaneous electrical signal strength inapproximate units of millivolts. The P-wave 121 has a smooth, normallyupward, that is, positive, waveform that indicates atrialdepolarization. The QRS complex often begins with the downwarddeflection of a Q-wave 122, followed by a larger upward deflection of anR-wave 123, and terminated with a downward waveform of the S-wave 124,collectively representative of ventricular depolarization. The T-wave125 is normally a modest upward waveform, representative of ventriculardepolarization, while the U-wave 126, often not directly observable,indicates the recovery period of the Purkinje conduction fibers.

Sampling of the R-to-R interval enables heart rate informationderivation. For instance, the R-to-R interval represents the ventricularrate and rhythm, while the P-to-P interval represents the atrial rateand rhythm. Importantly, the PR interval is indicative ofatrioventricular (AV) conduction time and abnormalities in the PRinterval can reveal underlying heart disorders, thus representinganother reason why the P-wave quality achievable by the ambulatoryelectrocardiography monitoring patch optimized for capturing lowamplitude cardiac action potential propagation described herein ismedically unique and important. The long-term observation of these ECGindicia, as provided through extended wear of the wearable monitor 12,provides valuable insights to the patient's cardiac function symptoms,and overall well-being.

Referring back to FIG. 12, each sampled ECG signal, in quantized anddigitized form, is processed by signal processing modules as specifiedin firmware (step 105), as described infra, and temporarily staged in abuffer (step 106), pending compression preparatory to storage in theflash memory 62 (step 107). Following compression, the compressed ECGdigitized sample is again buffered (step 108), then written to the flashmemory 62 (step 109) using the communications bus. Processing continues(step 110), so long as the monitoring recorder 14 remains connected tothe electrode patch 15 (and storage space remains available in the flashmemory 62), after which the processing loop is exited (step 110) andexecution terminates. Still other operations and steps are possible.

The microcontroller 61 operates under modular micro program control asspecified in firmware, and the program control includes processing ofthe analog ECG signal output by the ECG front end circuit 63. FIG. 14 isa functional block diagram showing the signal processing functionality130 of the microcontroller 61. The microcontroller 61 operates undermodular micro program control as specified in firmware 132. The firmwaremodules 132 include high and low pass filtering 133, and compression134. Other modules are possible. The microcontroller 61 has a built-inADC, although ADC functionality could also be provided in the firmware132.

The ECG front end circuit 63 first outputs an analog ECG signal, whichthe ADC 131 acquires, samples and converts into an uncompressed digitalrepresentation. The microcontroller 61 includes one or more firmwaremodules 133 that perform filtering. In one embodiment, three low passfilters and two high pass filters are used. Following filtering, thedigital representation of the cardiac activation wave front amplitudesare compressed by a compression module 134 before being written out tostorage 135.

The download station executes a communications or offload program(“Offload”) or similar program that interacts with the monitor recorder14 via the external connector 65 to retrieve the stored ECG monitoringdata. FIG. 15 is a functional block diagram showing the operations 140performed by the download station. The download station could be aserver, personal computer, tablet or handheld computer, smart mobiledevice, or purpose-built programmer designed specific to the task ofinterfacing with a monitor recorder 14. Still other forms of downloadstation are possible, including download stations connected throughwireless interfacing using, for instance, a smart phone connected to themonitor recorder 14 through Bluetooth or Wi-Fi.

The download station is responsible for offloading stored ECG monitoringdata from a monitor recorder 14 and includes an electro mechanicaldocking interface by which the monitor recorder 14 is connected at theexternal connector 65. The download station operates under programmablecontrol as specified in software 141. The stored ECG monitoring dataretrieved from storage 142 on a monitor recorder 14 is firstdecompressed by a decompression module 143, which converts the storedECG monitoring data back into an uncompressed digital representationmore suited to signal processing than a compressed signal. The retrievedECG monitoring data may be stored into local storage for archivalpurposes, either in original compressed form, or as uncompressed.

The download station can include an array of filtering modules. Forinstance, a set of phase distortion filtering tools 144 may be provided,where corresponding software filters can be provided for each filterimplemented in the firmware executed by the microcontroller 61. Thedigital signals are run through the software filters in a reversedirection to remove phase distortion. For instance, a 45 Hertz high passfilter in firmware may have a matching reverse 45 Hertz high pass filterin software. Most of the phase distortion is corrected, that is,canceled to eliminate noise at the set frequency, but data at otherfrequencies in the waveform remain unaltered. As well, bidirectionalimpulse infinite response (IIR) high pass filters and reverse direction(symmetric) IIR low pass filters can be provided. Data is run throughthese filters first in a forward direction, then in a reverse direction,which generates a square of the response and cancels out any phasedistortion. This type of signal processing is particularly helpful withimproving the display of the ST-segment by removing low frequency noise.

An automatic gain control (AGC) module 145 can also be provided toadjust the digital signals to a usable level based on peak or averagesignal level or other metric. AGC is particularly critical tosingle-lead ECG monitors, where physical factors, such as the tilt ofthe heart, can affect the electrical field generated. On three-leadHolter monitors, the leads are oriented in vertical, horizontal anddiagonal directions. As a result, the horizontal and diagonal leads maybe higher amplitude and ECG interpretation will be based on one or bothof the higher amplitude leads. In contrast, the electrocardiographymonitor 12 has only a single lead that is oriented in the verticaldirection, so variations in amplitude will be wider than available withmulti-lead monitors, which have alternate leads to fall back upon.

In addition, AGC may be necessary to maintain compatibility withexisting ECG interpretation software, which is typically calibrated formulti-lead ECG monitors for viewing signals over a narrow range ofamplitudes. Through the AGC module 145, the gain of signals recorded bythe monitor recorder 14 of the electrocardiography monitor 12 can beattenuated up (or down) to work with FDA-approved commercially availableECG interpretation.

AGC can be implemented in a fixed fashion that is uniformly applied toall signals in an ECG recording, adjusted as appropriate on arecording-by-recording basis. Typically, a fixed AGC value is calculatedbased on how an ECG recording is received to preserve the amplituderelationship between the signals. Alternatively, AGC can be varieddynamically throughout an ECG recording, where signals in differentsegments of an ECG recording are amplified up (or down) by differingamounts of gain.

Typically, the monitor recorder 14 will record a high resolution, lowfrequency signal for the P-wave segment. However, for some patients, theresult may still be a visually small signal. Although high resolution ispresent, the unaided eye will normally be unable to discern the P-wavesegment. Therefore, gaining the signal is critical to visually depictingP-wave detail. This technique works most efficaciously with a raw signalwith low noise and high resolution, as generated by the monitor recorder14. Automatic gain control applied to a high noise signal will onlyexacerbate noise content and be self-defeating.

Finally, the download station can include filtering modules specificallyintended to enhance P-wave content. For instance, a P-wave base boostfilter 146, which is a form of pre-emphasis filter, can be applied tothe signal to restore missing frequency content or to correct phasedistortion. Still other filters and types of signal processing arepossible.

Conventional ECG monitors, like Holter monitors, invariably requirespecialized training on proper placement of leads and on the operationof recording apparatuses, plus support equipment purpose-built toretrieve, convert, and store ECG monitoring data. In contrast, theelectrocardiography monitor 12 simplifies monitoring from end to end,starting with placement, then with use, and finally with data retrieval.FIGS. 16A-C are functional block diagrams respectively showing practicaluses 150, 160, 170 of the extended wear electrocardiography monitors 12of FIGS. 1 and 2. The combination of a flexible extended wear electrodepatch and a removable reusable (or single use) monitor recorder empowersphysicians and patients alike with the ability to readily performlong-term ambulatory monitoring of the ECG and physiology.

Especially when compared to existing Holter-type monitors and monitoringpatches placed in the upper pectoral region, the electrocardiographymonitor 12 offers superior patient comfort, convenience anduser-friendliness. To start, the electrode patch 15 is specificallydesigned for ease of use by a patient (or caregiver); assistance byprofessional medical personnel is not required. Moreover, the patient isfree to replace the electrode patch 15 at any time and need not wait fora doctor's appointment to have a new electrode patch 15 placed. Inaddition, the monitor recorder 14 operates automatically and the patientonly need snap the monitor recorder 14 into place on the electrode patch15 to initiate ECG monitoring. Thus, the synergistic combination of theelectrode patch 15 and monitor recorder 14 makes the use of theelectrocardiography monitor 12 a reliable and virtually foolproof way tomonitor a patient's ECG and physiology for an extended, or evenopen-ended, period of time.

In simplest form, extended wear monitoring can be performed by using thesame monitor recorder 14 inserted into a succession of fresh newelectrode patches 15. As needed, the electrode patch 15 can be replacedby the patient (or caregiver) with a fresh new electrode patch 15throughout the overall monitoring period. Referring first to FIG. 16A,at the outset of monitoring, a patient adheres a new electrode patch 15in a location at the sternal midline 16 (or immediately to either sideof the sternum 13) oriented top-to-bottom (step 151). The placement ofthe wearable monitor in a location at the sternal midline (orimmediately to either side of the sternum), with its unique narrow“hourglass”-like shape, significantly improves the ability of thewearable monitor to cutaneously sense cardiac electrical potentialsignals, particularly the P-wave (or atrial activity) and, to a lesserextent, the QRS interval signals indicating ventricular activity in theECG waveforms.

Placement involves simply adhering the electrode patch 15 on the skinalong the sternal midline 16 (or immediately to either side of thesternum 13). Patients can easily be taught to find the physicallandmarks on the body necessary for proper placement of the electrodepatch 15. The physical landmarks are locations on the surface of thebody that are already familiar to patients, including the inter-mammarycleft between the breasts above the manubrium (particularly easilylocatable by women and gynecomastic men), the sternal notch immediatelyabove the manubrium, and the Xiphoid process located at the bottom ofthe sternum. Empowering patients with the knowledge to place theelectrode patch 15 in the right place ensures that the ECG electrodeswill be correctly positioned on the skin, no matter the number of timesthat the electrode patch 15 is replaced.

A monitor recorder 14 is snapped into the non-conductive receptacle 25on the outward-facing surface of the electrode patch 15 (step 152). Themonitor recorder 14 draws power externally from a battery provided inthe non-conductive receptacle 25. In addition, the battery is replacedeach time that a fresh new electrode patch 15 is placed on the skin,which ensures that the monitor recorder 14 is always operating with afresh power supply and minimizing the chances of a loss of monitoringcontinuity due to a depleted battery source.

By default, the monitor recorder 14 automatically initiates monitoringupon sensing body surface potentials through the pair of ECG electrodes(step 153). In a further embodiment, the monitor recorder 14 can beconfigured for manual operation, such as by using the tactile feedbackbutton 66 on the outside of the sealed housing 50, or otheruser-operable control. In an even further embodiment, the monitorrecorder 14 can be configured for remotely-controlled operation byequipping the monitor recorder 14 with a wireless transceiver, such asdescribed in commonly-assigned U.S. Pat. No. 9,433,367, issued Sep. 6,2016, the disclosure of which is incorporated by reference. The wirelesstransceiver allows wearable or mobile communications devices towirelessly interface with the monitor recorder 14.

A key feature of the extended wear electrocardiography monitor 12 is theability to monitor ECG and physiological data for an extended period oftime, which can be well in excess of the 14 days currently pitched asbeing achievable by conventional ECG monitoring approaches. In a furtherembodiment, ECG monitoring can even be performed over an open-ended timeperiod, as further explained infra. The monitor recorder 14 is reusableand, if so desired, can be transferred to successive electrode patches15 to ensure continuity of monitoring. At any point during ECGmonitoring, a patient (or caregiver) can remove the monitor recorder 14(step 154) and replace the electrode patch 15 currently being worn witha fresh new electrode patch 15 (step 151). The electrode patch 15 mayneed to be replaced for any number of reasons. For instance, theelectrode patch 15 may be starting to come off after a period of wear orthe patient may have skin that is susceptible to itching or irritation.The wearing of ECG electrodes can aggravate such skin conditions. Thus,a patient may want or need to periodically remove or replace ECGelectrodes during a long-term ECG monitoring period, whether to replacea dislodged electrode, reestablish better adhesion, alleviate itching orirritation, allow for cleansing of the skin, allow for showering andexercise, or for other purpose.

Following replacement, the monitor recorder 14 is again snapped into theelectrode patch 15 (step 152) and monitoring resumes (step 153). Theability to transfer the same monitor recorder 14 to successive electrodepatches 15 during a period of extended wear monitoring is advantageousnot to just diagnose cardiac rhythm disorders and other physiologicalevents of potential concern, but to do extremely long term monitoring,such as following up on cardiac surgery, ablation procedures, or medicaldevice implantation. In these cases, several weeks of monitoring or moremay be needed. In addition, some IMDs, such as pacemakers or implantablecardioverter defibrillators, incorporate a loop recorder that willcapture cardiac events over a fixed time window. If the telemetryrecorded by the IMD is not downloaded in time, cardiac events thatoccurred at a time preceding the fixed time window will be overwrittenby the IMD and therefore lost. The monitor recorder 14 providescontinuity of monitoring that acts to prevent loss of cardiac eventdata. In a further embodiment, the firmware executed by themicrocontroller 61 of the monitor recorder 14 can be optimized forminimal power consumption and additional flash memory for storingmonitoring data can be added to achieve a multi-week monitor recorder 14that can be snapped into a fresh new electrode patch 15 every sevendays, or other interval, for weeks or even months on end.

Upon the conclusion of monitoring, the monitor recorder 14 is removed(step 154) and recorded ECG and physiological telemetry are downloaded(step 155). For instance, a download station can be physicallyinterfaced to the external connector 65 of the monitor recorder 14 toinitiate and conduct downloading, as described supra with reference toFIG. 15.

In a further embodiment, the monitoring period can be of indeterminateduration. Referring next to FIG. 16B, a similar series of operations arefollowed with respect to replacement of electrode patches 15,reinsertion of the same monitor recorder 14, and eventual download ofECG and physiological telemetry (steps 161-165), as described supra withreference to FIG. 16A. However, the flash memory 62 (shown in FIG. 9) inthe circuitry 60 of the monitor recorder 14 has a finite capacity.Following successful downloading of stored data, the flash memory 62 canbe cleared to restore storage capacity and monitoring can resume oncemore, either by first adhering a new electrode patch 15 (step 161) or bysnapping the monitor recorder 14 into an already-adhered electrode patch15 (step 162). The foregoing expanded series of operations, to includereuse of the same monitor recorder 14 following data download, allowsmonitoring to continue indefinitely and without the kinds ofinterruptions that often affect conventional approaches, including theretrieval of monitoring data only by first making an appointment with amedical professional.

In a still further embodiment, when the monitor recorder 14 is equippedwith a wireless transceiver, the use of a download station can beskipped. Referring last to FIG. 16C, a similar series of operations arefollowed with respect to replacement of electrode patches 15 andreinsertion of the same monitor recorder 14 (steps 171-174), asdescribed supra with reference to FIG. 16A. However, recorded ECG andphysiological telemetry are downloaded wirelessly (step 175), such asdescribed in commonly-assigned U.S. patent application Ser. No.14/082,071, cited supra. The recorded ECG and physiological telemetrycan even be downloaded wirelessly directly from a monitor recorder 14during monitoring while still snapped into the non-conductive receptacle25 on the electrode patch 15. The wireless interfacing enablesmonitoring to continue for an open-ended period of time, as thedownloading of the recorded ECG and physiological telemetry willcontinually free up onboard storage space. Further, wireless interfacingsimplifies patient use, as the patient (or caregiver) only need worryabout placing (and replacing) electrode patches 15 and inserting themonitor recorder 14. Still other forms of practical use of the extendedwear electrocardiography monitors 12 are possible.

The circuit trace and ECG electrodes components of the electrode patch15 can be structurally simplified. In a still further embodiment, theflexible circuit 32 (shown in FIG. 5) and distal ECG electrode 38 andproximal ECG electrode 39 (shown in FIG. 6) are replaced with a pair ofinterlaced flexile wires. The interlacing of flexile wires through theflexible backing 20 reduces both manufacturing costs and environmentalimpact, as further described infra. The flexible circuit and ECGelectrodes are replaced with a pair of flexile wires that serve as bothelectrode circuit traces and electrode signal pickups. FIG. 17 is aperspective view 180 of an extended wear electrode patch 15 with aflexile wire electrode assembly in accordance with a still furtherembodiment. The flexible backing 20 maintains the unique narrow“hourglass”-like shape that aids long term extended wear, particularlyin women, as described supra with reference to FIG. 4. For clarity, thenon-conductive receptacle 25 is omitted to show the exposed batteryprinted circuit board 182 that is adhered underneath the non-conductivereceptacle 25 to the proximal end 31 of the flexible backing 20. Insteadof employing flexible circuits, a pair of flexile wires are separatelyinterlaced or sewn into the flexible backing 20 to serve as circuitconnections for an anode electrode lead and for a cathode electrodelead.

To form a distal electrode assembly, a distal wire 181 is interlacedinto the distal end 30 of the flexible backing 20, continues along anaxial path through the narrow longitudinal midsection of the elongatedstrip, and electrically connects to the battery printed circuit board182 on the proximal end 31 of the flexible backing 20. The distal wire181 is connected to the battery printed circuit board 182 by strippingthe distal wire 181 of insulation, if applicable, and interlacing orsewing the uninsulated end of the distal wire 181 directly into anexposed circuit trace 183. The distal wire-to-battery printed circuitboard connection can be made, for instance, by back stitching the distalwire 181 back and forth across the edge of the battery printed circuitboard 182. Similarly, to form a proximal electrode assembly, a proximalwire (not shown) is interlaced into the proximal end 31 of the flexiblebacking 20. The proximal wire is connected to the battery printedcircuit board 182 by stripping the proximal wire of insulation, ifapplicable, and interlacing or sewing the uninsulated end of theproximal wire directly into an exposed circuit trace 184. The resultingflexile wire connections both establish electrical connections and helpto affix the battery printed circuit board 182 to the flexible backing20.

The battery printed circuit board 182 is provided with a batterycompartment 36. A set of electrical pads 34 are formed on the batteryprinted circuit board 182. The electrical pads 34 electrically interfacethe battery printed circuit board 182 with a monitor recorder 14 whenfitted into the non-conductive receptacle 25. The battery compartment 36contains a spring 185 and a clasp 186, or similar assembly, to hold abattery (not shown) in place and electrically interfaces the battery tothe electrical pads 34 through a pair battery leads 187 for powering theelectrocardiography monitor 14. Other types of battery compartment arepossible. The battery contained within the battery compartment 36 can bereplaceable, rechargeable, or disposable.

In a yet further embodiment, the circuit board and non-conductivereceptacle 25 are replaced by a combined housing that includes a batterycompartment and a plurality of electrical pads. The housing can beaffixed to the proximal end of the elongated strip through theinterlacing or sewing of the flexile wires or other wires or threads.

The core of the flexile wires may be made from a solid, stranded, orbraided conductive metal or metal compounds. In general, a solid wirewill be less flexible than a stranded wire with the same totalcross-sectional area, but will provide more mechanical rigidity than thestranded wire. The conductive core may be copper, aluminum, silver, orother material. The pair of the flexile wires may be provided asinsulated wire. In one embodiment, the flexile wires are made from amagnet wire from Belden Cable, catalogue number 8051, with a solid coreof AWG 22 with bare copper as conductor material and insulated bypolyurethane or nylon. Still other types of flexile wires are possible.In a further embodiment, conductive ink or graphene can be used to printelectrical connections, either in combination with or in place of theflexile wires.

In a still further embodiment, the flexile wires are uninsulated. FIG.18 is perspective view of the flexile wire electrode assembly from FIG.17, with a layer of insulating material 189 shielding a bare uninsulateddistal wire 181 around the midsection on the contact side of theflexible backing. On the contact side of the proximal and distal ends ofthe flexible backing, only the portions of the flexile wires serving aselectrode signal pickups are electrically exposed and the rest of theflexile wire on the contact side outside of the proximal and distal endsare shielded from electrical contact. The bare uninsulated distal wire181 may be insulated using a layer of plastic, rubber-like polymers, orvarnish, or by an additional layer of gauze or adhesive (ornon-adhesive) gel. The bare uninsulated wire 181 on the non-contact sideof the flexible backing may be insulated or can simply be leftuninsulated.

Both end portions of the pair of flexile wires are typically placeduninsulated on the contact surface of the flexible backing 20 to form apair of electrode signal pickups. FIG. 19 is a bottom view 190 of theflexile wire electrode assembly as shown in FIG. 17. When adhered to theskin during use, the uninsulated end portions of the distal wire 181 andthe proximal wire 191 enable the monitor recorder 14 to measure dermalelectrical potential differentials. At the proximal and distal ends ofthe flexible backing 20, the uninsulated end portions of the flexilewires may be configured into an appropriate pattern to provide anelectrode signal pickup, which would typically be a spiral shape formedby guiding the flexile wire along an inwardly spiraling pattern. Thesurface area of the electrode pickups can also be variable, such as byselectively removing some or all of the insulation on the contactsurface. For example, an electrode signal pickup arranged by sewinginsulated flexile wire in a spiral pattern could have a crescent-shapedcutout of uninsulated flexile wire facing towards the signal source.

In a still yet further embodiment, the flexile wires are left freelyriding on the contact surfaces on the distal and proximal ends of theflexible backing, rather than being interlaced into the ends of theflexible backing 20. FIG. 20 is a bottom view 200 of a flexile wireelectrode assembly in accordance with a still yet further embodiment.The distal wire 181 is interlaced onto the midsection and extends anexposed end portion 192 onto the distal end 30. The proximal wire 191extends an exposed end portion 193 onto the proximal end 31. The exposedend portions 192 and 193, not shielded with insulation, are furtherembedded within an electrically conductive adhesive 201. The adhesive201 makes contact to skin during use and conducts skin electricalpotentials to the monitor recorder 14 (not shown) via the flexile wires.The adhesive 201 can be formed from electrically conductive,non-irritating adhesive, such as hydrocolloid.

The distal wire 181 is interlaced or sewn through the longitudinalmidsection of the flexible backing 20 and takes the place of theflexible circuit 32. FIG. 21 is a perspective view showing thelongitudinal midsection of the flexible backing of the electrodeassembly from FIG. 17. Various stitching patterns may be adopted toprovide a proper combination of rigidity and flexibility. In simplestform, the distal wire 181 can be manually threaded through a pluralityof holes provided at regularly-spaced intervals along an axial pathdefined between the battery printed circuit board 182 (not shown) andthe distal end 30 of the flexible backing 20. The distal wire 181 can bethreaded through the plurality of holes by stitching the flexile wire asa single “thread.” Other types of stitching patterns or stitching ofmultiple “threads” could also be used, as well as using a sewing machineor similar device to machine-stitch the distal wire 181 into place, asfurther described infra. Further, the path of the distal wire 181 neednot be limited to a straight line from the distal to the proximal end ofthe flexible backing 20.

While the invention has been particularly shown and described asreferenced to the embodiments thereof, those skilled in the art willunderstand that the foregoing and other changes in form and detail maybe made therein without departing from the spirit and scope.

What is claimed is:
 1. A monitor recorder optimized forelectrocardiographic potential processing, comprising: a housing adaptedto be coupled to at least one electrocardiographic electrode; and anelectronic circuitry provided within the housing and comprising: anelectrocardiographic front end circuit under the control of a low-powermicrocontroller and configured to sense electrocardiographic potentialsthrough the at least one electrocardiographic electrode and to outputelectrocardiographic signals representative of cardiac activation wavefront amplitudes, the electrocardiographic front end circuit comprisingan operational amplifier and an AC coupling capacitor through which acurrent of the sensed electrocardiographic potentials sequentiallypasses, wherein the operational amplifier amplifies the current; thelow-power microcontroller operable to execute over an extended periodunder modular micro program control as specified in firmware and furtheroperable to acquire samples of the output electrocardiographic signals;and a non-volatile memory electrically interfaced with themicrocontroller and operable to continuously store the samples of theelectrocardiographic signals throughout the extended period.
 2. Amonitor recorder in accordance with claim 1, wherein the AC couplingcapacitor applies a high-pass filter on the passing current.
 3. Amonitor recorder in accordance with claim 1, further comprising: afurther operational amplifier through which the current passes afterpassing through the AC coupling capacitor.
 4. A monitor recorder inaccordance with claim 3, further comprising: a resistor and a capacitorthrough which the current sequentially passes after passing through thefurther operational amplifier.
 5. A monitor recorder in accordance withclaim 4, wherein the resistor and the capacitor apply an anti-aliasinglow pass filter to the current.
 6. A monitor recorder in accordance withclaim 1, further comprising: a protection resistor through which thecurrent passes prior to passing through the operational amplifier.
 7. Amonitor recorder in accordance with claim 6, further comprising: an ACcoupling capacitor, a termination resistor, and a filter capacitorthrough which the current passes after passing through the protectionresistor and prior to passing through the operational amplifier.
 8. Amonitor recorder in accordance with claim 1, further comprising: ananalog-to-digital converter operable to convert the electrocardiographicsignals into digital representations of the cardiac activation wavefront amplitudes; one or more low pass filter comprised in the firmware;and one or more high pass filter comprised in the firmware, wherein thecardiac activation wave front amplitudes are passed through the at leastone low pass filter and the at least one high pass filter followingconversion into the digital representations.
 9. A monitor recorder inaccordance with claim 8, wherein the firmware comprises three of the lowpass filters.
 10. A monitor recorder in accordance with claim 8, whereinthe firmware comprises two of the high pass filters.
 11. A monitoroptimized for electrocardiographic potential processing, comprising: adisposable extended wear electrode patch, comprising: a flexible backingcomprising stretchable material defined as an elongated strip with anarrow longitudinal midsection; a pair of electrocardiographicelectrodes comprised on the contact surface of each end of the flexiblebacking, each electrocardiographic electrode conductively exposed fordermal adhesion and adapted to be positioned axially along a midline ofa sternum for capturing action potential propagation; a non-conductivereceptacle affixed to a non-contacting surface of the flexible backingand comprising an electro mechanical docking interface; and a pair offlexible circuit traces affixed at each end of the flexible backing witheach circuit trace connecting one of the electrocardiographic electrodesto the docking interface; and an electrocardiography monitor recorder,comprising: a wearable housing adapted to be coupled to a pair ofelectrocardiographic electrodes that are fitted for dermal placementalong the sternal midline; and an electronic circuitry provided withinthe wearable housing and comprising: an electrocardiographic front endcircuit under the control of a low-power microcontroller and configuredto sense electrocardiographic potentials through theelectrocardiographic electrodes and to output electrocardiographicsignals representative of cardiac activation wave front amplitudes, theelectrocardiographic front end circuit comprising an operationalamplifier and an AC coupling capacitor through which a current of thesensed electrocardiographic potentials sequentially passes, wherein theoperational amplifier amplifies the current; the low-powermicrocontroller operable to execute over an extended period undermodular micro program control as specified in firmware and furtheroperable to acquire samples of the output electrocardiographic signals;and a non-volatile memory electrically interfaced with themicrocontroller and operable to continuously store the samples of theelectrocardiographic signals throughout the extended period.
 12. Amonitor in accordance with claim 11, wherein the AC coupling capacitorapplies a high-pass filter on the passing current.
 13. A monitor inaccordance with claim 11, further comprising: a further operationalamplifier through which the current passes after passing through the ACcoupling capacitor.
 14. A monitor in accordance with claim 13, furthercomprising: a resistor and a capacitor through which the currentsequentially passes after passing through the further operationalamplifier.
 15. A monitor in accordance with claim 14, wherein theresistor and the capacitor apply an anti-aliasing low pass filter to thecurrent.
 16. A monitor in accordance with claim 11, further comprising:a protection resistor through which the current passes prior to passingthrough the operational amplifier.
 17. A monitor in accordance withclaim 16, further comprising: an AC coupling capacitor, a terminationresistor, and a filter capacitor through which the current passes afterpassing through the protection resistor and prior to passing through theoperational amplifier.
 18. A monitor in accordance with claim 11,further comprising: an analog-to-digital converter operable to convertthe electrocardiographic signals into digital representations of thecardiac activation wave front amplitudes; one or more low pass filtercomprised in the firmware; and one or more high pass filter comprised inthe firmware, wherein the cardiac activation wave front amplitudes arepassed through the at least one low pass filter and the at least onehigh pass filter following conversion into the digital representations.19. A monitor in accordance with claim 18, wherein the firmwarecomprises three of the low pass filters.
 20. A monitor in accordancewith claim 18, wherein the firmware comprises two of the high passfilters.